ASKLEPIOS Group remains on strategic course in Hamburg, Germany; HDH goes live, data-sharing boosts outpatient care access

ASKLEPIOS Group remains on strategic course in Hamburg, Germany; HDH goes live, data-sharing boosts outpatient care access

Asklepios - ASKLEPIOS Group remains on strategic course

ASKLEPIOS Group remains on strategic course

Health Data Hub, promissory notes, partnership with MSH and the Next Level Nursing initiative are key milestones

Number of patients increased to approximately 3.9 million

Revenue at EUR 6.4 billion with stable EAT margin of 2.4%

Despite challenging health policy and economic conditions, Asklepios Kliniken GmbH & Co. KGaA achieved stable growth in 2025. Our performance was largely driven by a forward-looking financing strategy, the consistent expansion of digital infrastructure and targeted initiatives aimed at sustainably strengthening staff development.

Year-on-year, the number of patients treated rose by 7.0% to just under 3.9 million. Bed capacity increased by 0.7% to 31,141, while the average number of full-time employees increased 4.5% year-on-year to over 53,000.

CEO Joachim Gemmel: “As Germany’s leading private family-owned hospital operator, we are committed to continuously improving and re-thinking the way we provide care to patients in terms of quality, accessibility and efficiency. The year 2025 has once again shown that we are on the right track with this approach.”

CEO Marco Walker: “Thanks to our strategic independence, we have the opportunity to undertake this journey on our own terms – with a clearly oriented, innovative approach and at a pace ensuring we do not lose sight of the quality we deliver to our patients.”

ASKLEPIOS remains in a solid position, with consolidated revenue at EUR 6,401.2 million. Consolidated earnings after tax (EAT) came to EUR 151.8 million, and the EAT margin was down one percentage point on the previous year at 2.3%.

A key component of the financing strategy in the 2025 financial year was the successful issue of a social promissory note by ASKLEPIOS in October amounting to EUR 600 million. With this transaction, the company covered its refinancing needs at an early stage, optimised the maturity profile of its financial liabilities and expanded its international investor base in a targeted manner. CFO Hafid Rifi explained: “The high level of international demand underscores the confidence in our strategy as well as in our ability to consistently combine economic stability with sustainable growth.”

With seven hospitals, including four maximum care facilities, ASKLEPIOS is one of the leading employers in the Hamburg healthcare sector and is purposefully expanding its training capacities together with the private Medical School Hamburg (MSH) in a number of ways, including establishing an additional university site in Harburg to complement the campus in Budapest. Our focus is on providing medical professionals with real-world experience at an early stage of their career. At the same time, the “NEXT LEVEL NURSING” initiative, supported by ASKLEPIOS, RHÖN-KLINIKUM AG and MEDICLIN AG, is driving forward the further development of nursing care through strategic recruitment, practical training, optimised processes and the integration of international professionals.

CMO Sara Sheikhzadeh emphasised: “Our guiding principle is clear: whoever attracts the best talent and retains it long term will shape what care looks like in the future. By maintaining flat hierarchies and open dialogue, and staying closely attuned to the needs of our patients, we build trust, stay on track, and get better and better at what we do. This makes ASKLEPIOS one of the most attractive employers in the German healthcare industry.”

Another key milestone was the go-live of the Health Data Hub (HDH) as part of our digital data infrastructure upgrade. Since November 2025, clinical and administrative data across the Group have been consolidated into a central, high-performance, and data protection-compliant data infrastructure. This opens up additional potential for the shift towards outpatient care, cross-sector networking and further medical specialisation.

ASKLEPIOS has a robust strategic and operational foundation in place to strengthen its position in the healthcare sector in the 2026 financial year. Our focus is on sharpening up clinical specialisations and the consistent utilisation of synergies and economies of scale within the Group within the framework of the integrated network model. We are also making targeted investments in the modernisation and improvement of our hospital sites in order to increase the sustainable performance of the site portfolio, strengthen our commitment to medical excellence and secure the future viability of the Group over the long term.

Personnel changes on the Management Board

Hafid Rifi (53) is stepping down from the Management Board of Asklepios Kliniken GmbH & Co. KGaA at his own request, effective 31 May 2026, to pursue an opportunity outside the company. At its most recent meeting on 21 April 2026, the company’s Supervisory Board reluctantly accepted his request. The Supervisory Board would like to thank Hafid Rifi for his achievements, his exceptional commitment and his integrity, and wishes him all the best for his future endeavours, both professionally and personally. Hafid Rifi will step down from his position on 31 May 2026.